Plain-English translation of NCT03827941 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing auricular transcutaneous electrical nerve stimulation (a gentle electrical stimulation applied to specific points on the ear) as a potential treatment for autism spectrum disorder in adults. Researchers will compare two different stimulation frequencies to see which one—if either—may help improve symptoms. The study focuses on adults with high-functioning autism who are between ages 18 and 60.
There are limited treatment options available to help manage symptoms of autism in adults, particularly those looking for non-medication approaches. This trial is exploring whether this ear stimulation treatment might offer a new way to support people with autism.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to receive one of two types of ear stimulation treatment. You'll attend sessions up to five times per week for three weeks, with each session lasting 30 minutes. During the treatment, small electrodes will deliver gentle electrical stimulation to specific points on your ear.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States
Sponsor
Massachusetts General Hospital
Enrollment target
~40 participants
Started
November 2022
Primary completion
September 2027
Age range
18 Years – 60 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sierra Hodges
MGH
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.